{
"source": "NIH ClinicalTrials.gov REST API v2",
"total_matches": 1975,
"returned": 1,
"studies": [
{
"nctId": "NCT07356024",
"briefTitle": "Effect of Acupressure on Blood Glucose And Anxiety in Elderly With Diabetes",
"overallStatus": "RECRUITING",
"phases": [
"NA"
],
"leadSponsor": "Abant Izzet Baysal University",
"enrollmentCount": 48,
"primaryContactName": "Saadet CAN ÇİÇEK",
"primaryContactEmail": "[email protected]",
"primaryContactPhone": "+905062846936",
"studyUrl": "https://clinicaltrials.gov/study/NCT07356024"
}
]
}
curl --location --request GET 'https://zylalabs.com/api/15169/us+doctor+npi+registry+api/40454/search+nih+clinical+trials+v2?condition=diabetes&limit=5' --header 'Authorization: Bearer YOUR_API_KEY'
{
"source": "U.S. CMS NPPES NPI Registry API v2.1",
"returned": 1,
"providers": [
{
"npi": "1982227625",
"enumerationType": "NPI-1",
"providerName": "TARIQ AL-SALEH",
"primarySpecialty": "Pharmacist, Ambulatory Care",
"city": "EL CAJON",
"state": "CA",
"postalCode": "920204454",
"phone": "786-445-2814",
"fax": "619-923-5881",
"authorizedOfficial": null,
"nppesUrl": "https://npiregistry.cms.hhs.gov/provider-view/1982227625"
}
]
}
curl --location --request GET 'https://zylalabs.com/api/15169/us+doctor+npi+registry+api/40455/search+us+npi+healthcare+providers?taxonomy=Cardiology&state=CA&limit=5' --header 'Authorization: Bearer YOUR_API_KEY'
{
"source": "EMBL-EBI Europe PMC & PubMed REST API",
"query": "crispr",
"total_matches": 243365,
"returned": 1,
"papers": [
{
"pmid": "42888301",
"pmcid": null,
"doi": "10.1007/10_2026_363",
"title": "Synthetic Biology Tools and Strategies for Microbial Cell Factory Construction.",
"journal": "Adv Biochem Eng Biotechnol",
"pubYear": 2027,
"citedByCount": 0,
"isOpenAccess": false,
"authorString": "Jiang J, Zhang X, Zhang L, Tan GY.",
"authorEmails": [
"[email protected]"
],
"abstractText": "Microbial cell factories have emerged as important platforms for the sustainable production of fuels, chemicals, pharmaceuticals, and other value-added bioproducts. Synthetic biology provides a systematic engineering framework for their construction and optimization through standardized biological parts, modular design, and iterative Design-Build-Test-Learn cycles. This chapter summarizes the major tools and strategies for developing microbial cell factories, beginning with the fundamental principles of synthetic biology and the characteristics of representative microbial chassis. Key genetic engineering approaches, including CRISPR-based genome editing, transcriptional and translational regulation, and modular DNA assembly, are discussed together with strategies for metabolic pathway design, enzyme engineering, flux balancing, and dynamic regulation. Genome-scale metabolic modeling, adaptive and directed evolution, and multi-omics analysis are further introduced as systems-level approaches for identifying engineering targets and improving cellular performance. In addition, emerging computational tools, machine learning, artificial intelligence, high-throughput screening, and laboratory automation are highlighted for their roles in accelerating strain development and closing the Design-Build-Test-Learn cycle. Finally, representative applications illustrate the translation of engineered microbial cell factories from laboratory-scale design to industrial biomanufacturing.",
"freePdfUrl": null,
"pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/42888301/"
}
]
}
curl --location --request GET 'https://zylalabs.com/api/15169/us+doctor+npi+registry+api/40456/search+pubmed+and+europe+pmc+papers?q=crispr&limit=5' --header 'Authorization: Bearer YOUR_API_KEY'
After signing up, every developer is assigned a personal API access key, a unique combination of letters and digits provided to access to our API endpoint. To authenticate with the US Doctor NPI Registry API simply include your bearer token in the Authorization header.
| Header | Description |
|---|---|
Authorization
|
Required
Should be Bearer access_key. See "Your API Access Key" above when you are subscribed.
|
No long-term commitment. Upgrade, downgrade, or cancel anytime.
Unified medical intelligence API over NIH ClinicalTrials.gov v2, CMS US NPI v2.1 providers, and EMBL-EBI Europe PMC/PubMed.
NIH ClinicalTrials.gov v2, U.S. CMS NPI Registry v2.1, and EMBL-EBI Europe PMC/PubMed.
It returns trial identifiers, titles, recruitment status, study phases, lead sponsors, enrollment counts, primary contact details, and ClinicalTrials.gov URLs. Results also include total matches and the number returned.
You can search studies by condition, intervention, phase, or recruitment status. These filters help identify relevant trials, such as recruiting studies for a specific disease or intervention.
Provider records can include the NPI, enumeration type, name, primary specialty, city, state, postal code, phone, fax, authorized official, and an official NPPES profile URL.
Searches can be customized with a specialty, city, state, or NPI number. Results may represent individual providers or organizations, identified by the enumeration type such as NPI-1.
Publication results may include PMID, PMCID, DOI, title, journal, publication year, citation count, authors, author email addresses, abstract text, open-access status, and available PDF links.
Submit a biomedical query, such as “crispr,” to retrieve matching publications. The response provides the query, total matches, returned count, and an array of paper records for further filtering or analysis.
Each endpoint returns structured JSON. A response typically identifies the source, reports match or return counts, and places records in a collection such as `studies`, `providers`, or `papers`. Some fields may be null or absent when source data is unavailable.
Check `total_matches` and `returned` before processing results. Treat nullable fields such as `authorizedOfficial` or `pmcid` as optional, and use stable identifiers like NCT IDs, NPIs, PMIDs, or DOIs for deduplication and linking.
To obtain your API key, first sign in to your account and navigate to the API you want to use. From the API's Pricing section, choose a plan and complete the subscription process. Once subscribed, return to the API page and you will see your API Access Key displayed at the top of the documentation page. You can use this key to authenticate your requests.
You can’t switch APIs during the free trial. If you subscribe to a different API, your trial will end and the new subscription will start as a paid plan.
The free trial lasts for 7 days and allows you to make up to 50 API requests.
No, the free trial is available only once, so we recommend using it on the API that interests you the most. Most of our APIs offer a free trial, but some may not include this option.
Yes. If the API offers a free trial, you will see a "Free 7-Day Trial" option in its Pricing section. The trial lasts for 7 days and allows up to 50 API requests, enabling you to evaluate the API before subscribing to a paid plan.
Zyla API Hub is like a big store for APIs, where you can find thousands of them all in one place. We also offer dedicated support and real-time monitoring of all APIs. Once you sign up, you can pick and choose which APIs you want to use. Just remember, each API needs its own subscription. But if you subscribe to multiple ones, you'll use the same key for all of them, making things easier for you.
You can monitor your API usage through the response headers included with every request:
x-zyla-api-calls-monthly-used: Shows the total number of API requests you have used during the current billing period.
x-zyla-api-calls-monthly-remaining: Shows the number of API requests you have remaining for the current billing period.
Yes, you can cancel your subscription at any time. Simply go to the Pricing section of the API you're subscribed to and click the "Unsubscribe" button.
Please note that upgrades, downgrades, and cancellations take effect immediately. Once your subscription is canceled, access to the service will end immediately, regardless of any remaining API calls in your quota.
Please have a look at our Refund Policy: https://zylalabs.com/terms#refund